Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Aminobenzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 4/20 | 0.55 |
| ▸ | DRD1 known ✓ | P21728 | 1/20 | 0.55 |
| ▸ | GABRP known ✓ | O00591 | 1/20 | 0.48 |
| ▸ | GABRD known ✓ | O14764 | 1/20 | 0.48 |
| ▸ | GABRA1 known ✓ | P14867 | 1/20 | 0.48 |
| ▸ | GABRB1 known ✓ | P18505 | 1/20 | 0.48 |
| ▸ | GABRG2 known ✓ | P18507 | 1/20 | 0.48 |
| ▸ | GABRB3 known ✓ | P28472 | 1/20 | 0.48 |
| ▸ | GABRA5 known ✓ | P31644 | 1/20 | 0.48 |
| ▸ | GABRA3 known ✓ | P34903 | 1/20 | 0.48 |
| ▸ | GABRA2 known ✓ | P47869 | 1/20 | 0.48 |
| ▸ | GABRB2 known ✓ | P47870 | 1/20 | 0.48 |
| ▸ | GABRA4 known ✓ | P48169 | 1/20 | 0.48 |
| ▸ | GABRE known ✓ | P78334 | 1/20 | 0.48 |
| ▸ | GABRA6 known ✓ | Q16445 | 1/20 | 0.48 |
| ▸ | GABRG1 known ✓ | Q8N1C3 | 1/20 | 0.48 |
| ▸ | GABRG3 known ✓ | Q99928 | 1/20 | 0.48 |
| ▸ | GABRQ known ✓ | Q9UN88 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aminobenzoic Acid SCHEMBL11038536 | 1.00 | TSHR (0.67) | TSHRTP53SRD5A2CA1CA2 | |
| Aminobenzoic Acid SCHEMBL6621697 | 1.00 | TSHR (0.67) | TSHRTP53SRD5A2CA1CA2 | |
| Terephthalic Acid SCHEMBL9717815 | 0.97 | TSHR (0.71) | TSHRTP53SRD5A2CA1CA2 | |
| Aminobenzoic Acid SCHEMBL8249 | 0.97 | TSHR (0.71) | TSHRTP53SRD5A2CA1CA2 | |
| Terephthalic Acid SCHEMBL7648718 | 0.97 | TSHR (0.71) | TSHRTP53SRD5A2CA1CA2 | |
| Aminobenzoic Acid SCHEMBL1768920 | 0.97 | TSHR (0.71) | TSHRTP53SRD5A2CA1CA2 | |
| Aminobenzoic Acid SCHEMBL23121593 | 0.94 | TSHR (0.67) | TSHRTP53SRD5A2CA1CA2 | |
| Aminobenzoic Acid SCHEMBL9317391 | 0.94 | TSHR (0.67) | TSHRTP53SRD5A2CA1CA2 | |
| Aminobenzoic Acid SCHEMBL25354995 | 0.94 | TSHR (0.67) | TSHRTP53SRD5A2CA1CA2 | |
| Aminobenzoic Acid SCHEMBL20549750 | 0.94 | TSHR (0.67) | TSHRTP53SRD5A2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 321 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119535851-A | Water vapor barrier electrochromic dimming film and packaging method thereof | 绍兴迪飞新材料有限公司 | 2025-02-28 | — | — | CN | claimed |
| US-20250049674-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST A MEROCYANINE AND A HYDROTROPE | L'OREAL (FR) | 2025-02-13 | — | — | US | claimed |
| US-20240423888-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST ONE MEROCYANINE AND AT LEAST ASCORBIC ACID AND/OR A DERIVATIVE THEREOF | L'OREAL (FR) | 2024-12-26 | — | — | US | claimed |
| CN-118870833-A | Perovskite solar cell with modified interface and preparation method thereof | 中国科学院广州能源研究所 | 2024-10-29 | — | — | CN | claimed |
| CN-118871078-A | Cosmetic or dermatological composition comprising at least a merocyanine and a hydrotrope | 欧莱雅 | 2024-10-29 | — | — | CN | claimed |
| EP-4447895-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST ONE MEROCYANINE AND AT LEAST ASCORBIC ACID AND/OR A DERIVATIVE THEREOF | L'OREAL (FR) | 2024-10-23 | — | — | EP | claimed |
| CN-118804735-A | Cosmetic and/or dermatological composition comprising at least one merocyanine and at least ascorbic acid and/or derivatives thereof | 莱雅公司 | 2024-10-18 | — | — | CN | claimed |
| CN-117416113-B | Lightweight multilayer multiband high-reflection TPU composite material for false target | 常州佳尔科仿真器材有限公司 | 2024-04-09 | — | — | CN | claimed |
| US-20240091302-A1 | CARBETOCIN DRUG PRODUCT AND PROCESS FOR PREPARING SAME | ACADIA PHARMACEUTICALS, INC.. (US) | 2024-03-21 | — | — | US | claimed |
| CN-117416113-A | Lightweight multilayer multiband high-reflection TPU composite material for false target | 常州佳尔科仿真器材有限公司 | 2024-01-19 | — | — | CN | claimed |
| US-6117527-A | RECORDING SHEET COMPRISING SUBSTRATE HAVING IMAGE-RECEIVING COATING ON SURFACE COMPRISING BINDER POLYMER AND SELECTED ADDITIVE; HIGH QUALITY IMAGES WITH REDUCED OR NO HAZE | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | claimed |
| EP-0763577-B1 | Fast drying, bleed-free ink-jet ink compositions | HEWLETT PACKARD CO (US) | 2000-04-26 | — | — | EP | claimed |
| US-6024786-A | CONTAINING NON-DEAGGLOMERATED PIGMENTS HAVING A PARTICLE SIZE BELOW SPECIFIED VALUE, WATER INSOLUBLE ORGANIC COMPOUND, AMPHIPHILE AND WATER; INK JET PRINTING | HEWLETT-PACKARD COMPANY (US) | 2000-02-15 | — | — | US | claimed |
| EP-0897808-A1 | Recording sheets and ink jet printing processes therewith | Xerox Corporation (US) | 1999-02-24 | — | — | EP | claimed |
| EP-0763578-A1 | Bleed-alleviated, waterfast, pigment-based, ink-jet ink compositions | Hewlett-Packard Company (US) | 1997-03-19 | — | — | EP | claimed |
| EP-0763579-A1 | Bleed alleviated aqueous pigment dispersion-based ink-jet ink compositions | Hewlett-Packard Company (US) | 1997-03-19 | — | — | EP | claimed |
| US-5565022-A | Fast drying, bleed-free ink-jet ink compositions | HEWLETT-PACKARD COMPANY (US) | 1996-10-15 | — | — | US | claimed |
| US-5531816-A | Bleed-alleviated, waterfast, pigment-based ink-jet ink compositions | HEWLETT-PACKARD COMPANY (US) | 1996-07-02 | — | — | US | claimed |
| EP-0235064-B1 | AROMATIC COMPOUNDS WITH AMIDE STRUCTURE, DERIVATIVES OF AMINO-BENZOIC ACIDS, HYDROXYBENZOIC ACIDS, CINNAMIC ACIDS, UROCANIC ACIDS AND BENZIMIDAZOLES, ABSORBING UVB AND/OR UVA | Robert, Dominique (FR) | 1992-06-17 | — | — | EP | claimed |
| US-4172938-A | Process for producing polyamides with lactam or urea solvent and CaCl2 | TEIJIN LIMITED (JP) | 1979-10-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240423888-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST ONE MEROCYANINE AND AT LEAST ASCORBIC ACID AND/OR A DERIVATIVE THEREOF | KRT18, PROC, DSC1 | CA2 797/4885DRD1 3476/4885GABRP 3790/4885 |
| US-20250049674-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST A MEROCYANINE AND A HYDROTROPE | NAPRT, NAMPT, NNMT | CA2 393/4885DRD1 4741/4885GABRP 1824/4885 |
| US-20240091302-A1 | CARBETOCIN DRUG PRODUCT AND PROCESS FOR PREPARING SAME | DCTD, PRKD2, NCAPD2 | CA2 4640/4885DRD1 121/4885GABRP 3380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.